Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Keros Therapeutics, Inc.”

12 pharma patents match "Keros Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "Keros Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “Keros Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12404313

    GDNF fusion polypeptides and methods of use thereof

    Keros Therapeutics, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  2. US 12364737

    Activin receptor type IIA variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  3. US 12350313

    Activin receptor type IIa variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  4. US 12331124

    ALK2 antibodies and methods of use thereof

    Keros Therapeutics, Inc. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  5. US 12269858

    Activin receptor type IIB variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  6. US 12071438

    Crystal forms of an ALK2 inhibitor

    Keros Therapeutics, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  7. US 11912750

    GDNF fusion polypeptides and methods of use thereof

    Keros Therapeutics, Inc. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  8. US 11884715

    Activin receptor type IIB variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  9. US 11717558

    Nucleic acid molecules encoding activin receptor type IIA variants

    Keros Therapeutics, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  10. US 11484573

    Activin receptor type IIa variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  11. US 11090361

    Activin receptor type IIa variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  12. US 11013785

    Activin receptor type IIA variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted